f0ar1h3a
2021-02-02
[思考]
@小斯新报道：
快手心通的小道消息和本周港股IPO焦点
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
社区成长助手
2021-02-02
社区成长助手
终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看
老虎社区创作指引
什么也没有了～
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":315675028,"tweetId":"315675028","gmtCreate":1612251000964,"gmtModify":1703759283746,"author":{"id":10000000000006968,"idStr":"10000000000006967","authorId":10000000000006968,"authorIdStr":"10000000000006967","name":"f0ar1h3a","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>[思考] </p></body></html>","htmlText":"<html><head></head><body><p>[思考] </p></body></html>","text":"[思考]","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/315675028","repostId":312567442,"repostType":1,"repost":{"magic":2,"id":312567442,"tweetId":"312567442","gmtCreate":1612169192182,"gmtModify":1703758158912,"author":{"id":279327367386116,"idStr":"279327367386116","authorId":279327367386116,"authorIdStr":"279327367386116","name":"小斯新报道","avatar":"https://static.tigerbbs.com/7ae5ca6ae332a96f7211e19a07d9c529","vip":2,"userType":2,"introduction":"美股市场达人&IPO小司机","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":13102,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/28ec3b6beb84932907c2a34259151d4a","width":"839","height":"469"},{"img":"https://static.tigerbbs.com/5626319876bed753bace30e35d08e345","width":"612","height":"271"}],"coverImages":[{"img":"https://static.tigerbbs.com/28ec3b6beb84932907c2a34259151d4a","width":"839","height":"469"}],"title":"快手心通的小道消息和本周港股IPO焦点","extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01024\">$快手科技(01024)$</a> 和<a href=\"https://laohu8.com/S/02160\">$心通医疗-B(02160)$</a> 本周开奖。</p> <p>拒今天传的小道消息，快手的甲组尾（400手）也和乙组头（500手）各稳中一手。对于首发115港元的价格来说，在场外市场叫嚣的成交价已经高于210港元，甚至有传中金香港已经<span style=\"color:rgba(255,0,0,1);\"><b>把价格叫到260港元，相当于涨幅126%！</b></span></p> <p>而这样的话，<span style=\"color:rgba(255,0,0,1);\"><b>快手市值也将达到1.068万亿港元、1369亿美元。</b></span></p> <p><img src=\"https://static.tigerbbs.com/5626319876bed753bace30e35d08e345\" tg-width=\"612\" tg-height=\"271\"></p> <p>同时，心通医疗的12.2港元的价格，也在场外被炒到30港元，涨幅145%！</p> <p>但毕竟这只是小道消息，可以确定的一件事是中签率非常低！快手满足个甲尾的话，心通是有可能整个甲组都无法稳中。</p> <p>另外，1月31日，诺辉健康通过了港交所聆讯。本来它是有可能跟快手重叠的另一家公司，看来是避让了。</p> <p>诺辉健康是中国癌症早筛第一股，美国上市公司中比较有名的是<a href=\"https://laohu8.com/S/EXAS\">$精密科学(EXAS)$</a> ，二级市场表现也是比较不错。</p> <p><img src=\"https://static.tigerbbs.com/28ec3b6beb84932907c2a34259151d4a\" tg-width=\"839\" tg-height=\"469\"></p> <p>诺辉健康目前产品管线覆盖了中国10大高发癌种的3个，分别是结直肠癌、胃癌和宫颈癌，三大市场预计到2030年均将突破百亿。</p> <p>本周应该在路演，现在就看估值水如何以及何时开启招股，早的话本周五就可以开始准备，<span style=\"color:rgba(255,0,0,1);\"><b>不过大概率还是要经过春节假期</b></span>了！</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/01024\">$快手科技(01024)$</a> 和<a href=\"https://laohu8.com/S/02160\">$心通医疗-B(02160)$</a> 本周开奖。</p> <p>拒今天传的小道消息，快手的甲组尾（400手）也和乙组头（500手）各稳中一手。对于首发115港元的价格来说，在场外市场叫嚣的成交价已经高于210港元，甚至有传中金香港已经<span style=\"color:rgba(255,0,0,1);\"><b>把价格叫到260港元，相当于涨幅126%！</b></span></p> <p>而这样的话，<span style=\"color:rgba(255,0,0,1);\"><b>快手市值也将达到1.068万亿港元、1369亿美元。</b></span></p> <p><img src=\"https://static.tigerbbs.com/5626319876bed753bace30e35d08e345\" tg-width=\"612\" tg-height=\"271\"></p> <p>同时，心通医疗的12.2港元的价格，也在场外被炒到30港元，涨幅145%！</p> <p>但毕竟这只是小道消息，可以确定的一件事是中签率非常低！快手满足个甲尾的话，心通是有可能整个甲组都无法稳中。</p> <p>另外，1月31日，诺辉健康通过了港交所聆讯。本来它是有可能跟快手重叠的另一家公司，看来是避让了。</p> <p>诺辉健康是中国癌症早筛第一股，美国上市公司中比较有名的是<a href=\"https://laohu8.com/S/EXAS\">$精密科学(EXAS)$</a> ，二级市场表现也是比较不错。</p> <p><img src=\"https://static.tigerbbs.com/28ec3b6beb84932907c2a34259151d4a\" tg-width=\"839\" tg-height=\"469\"></p> <p>诺辉健康目前产品管线覆盖了中国10大高发癌种的3个，分别是结直肠癌、胃癌和宫颈癌，三大市场预计到2030年均将突破百亿。</p> <p>本周应该在路演，现在就看估值水如何以及何时开启招股，早的话本周五就可以开始准备，<span style=\"color:rgba(255,0,0,1);\"><b>不过大概率还是要经过春节假期</b></span>了！</p></body></html>","text":"$快手科技(01024)$ 和$心通医疗-B(02160)$ 本周开奖。 拒今天传的小道消息，快手的甲组尾（400手）也和乙组头（500手）各稳中一手。对于首发115港元的价格来说，在场外市场叫嚣的成交价已经高于210港元，甚至有传中金香港已经把价格叫到260港元，相当于涨幅126%！ 而这样的话，快手市值也将达到1.068万亿港元、1369亿美元。 同时，心通医疗的12.2港元的价格，也在场外被炒到30港元，涨幅145%！ 但毕竟这只是小道消息，可以确定的一件事是中签率非常低！快手满足个甲尾的话，心通是有可能整个甲组都无法稳中。 另外，1月31日，诺辉健康通过了港交所聆讯。本来它是有可能跟快手重叠的另一家公司，看来是避让了。 诺辉健康是中国癌症早筛第一股，美国上市公司中比较有名的是$精密科学(EXAS)$ ，二级市场表现也是比较不错。 诺辉健康目前产品管线覆盖了中国10大高发癌种的3个，分别是结直肠癌、胃癌和宫颈癌，三大市场预计到2030年均将突破百亿。 本周应该在路演，现在就看估值水如何以及何时开启招股，早的话本周五就可以开始准备，不过大概率还是要经过春节假期了！","highlighted":2,"essential":2,"paper":2,"link":"https://laohu8.com/post/312567442","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["EXAS","02160","01024"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":846,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":995,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":3464580,"commentId":"3464580","gmtCreate":1612251228519,"gmtModify":1612251228519,"authorId":3527667803686145,"author":{"id":3527667803686145,"idStr":"3527667803686145","authorId":3527667803686145,"name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":315675028,"objectIdStr":"315675028","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/315675028"}
精彩评论